does pfizer make glp 1 drugs 2 Companies Poised to Capitalize on the Rise of GLP-1 Weight Loss Pfizer, Innovent GLP-1 drugs clear

For a mobile-centric workflow, confirm permissions and background data settings so the experience stays responsive without compromising privacy

Beyond its health implications, obesity causes a significant economic burden

GLP-1 & GIP: It retains the appetite suppression, gastric slowing, and insulin-boosting properties of Tirzepatide

Wharton S., Blevins T., Connery L., et al., Daily Oral GLP1 Receptor Agonist Orforglipron for Adults With Obesity, New England Journal of Medicine 389 (2023): 877888

GLP-1 medications are a newer class of weight loss treatments

While the exclusion of weight management treatment may limit reimbursement of GLP-1s, non-obesity/overweight diseases such as diabetes mellitus and certain cardiovascular conditions may be eligible for reimbursement because these indications are not excluded